Nykode Therapeutics
NYKD.OL
#8968
Rank
ยฃ63.89 M
Marketcap
ยฃ0.20
Share price
-1.88%
Change (1 day)
-87.01%
Change (1 year)

Revenue for Nykode Therapeutics (NYKD.OL)

Revenue in 2024 (TTM): ยฃ4.93 Million

According to Nykode Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ4.9 Million. In 2023 the company made a revenue of ยฃ10.12 Million an increase over the revenue in the year 2022 that were of ยฃ5.92 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nykode Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ4.93 M-51.32%
2023 ยฃ10.12 M70.92%
2022 ยฃ5.92 M-76.45%
2021 ยฃ25.16 M